Surgical treatment and operation time in human immunodeficiency virus-negative cryptococcal meningitis.
Zhao J; Department of Neurosurgery, Xiangya Hospital.
Zhao X; Department of Neurosurgery, Xiangya Hospital.
Yang S; Department of Neurosurgery, Xiangya Hospital.
Miao S; Department of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha.; Department of Pathology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
Liu Y; Department of Pathophysiology, Xiangya School of Medicine, Central South University, Changsha.
Medicine [Medicine (Baltimore)] 2020 Oct 16; Vol. 99 (42), pp. e22546.
Typ publikacji :
Imprint Name(s) :
Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
MeSH Terms :
Adolescent ; Adult ; Aged ; Child ; China ; Female ; Humans ; Male ; Meningitis, Cryptococcal/diagnostic imaging ; Meningitis, Cryptococcal/mortality ; Middle Aged
Srichatrapimuk S, Sungkanuparph S. Integrated therapy for HIV and cryptococcosis. AIDS Res Ther 2016;13:42.
Lofgren S, Abassi M, Rhein J, et al. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings. Expert Rev Anti Infect Ther 2017;15:331–40.
Henao-Martinez AF, Gross L, Mcnair B, et al. Risk factors for cryptococcal meningitis: a single United States center experience. Mycopathologia 2016;181:807–14.
Ndayishimiye E, Ross AJ. An audit of the screen-and-treat intervention to reduce cryptococcal meningitis in HIV-positive patients with low CD4 count. Afr J Prim Health Care Fam Med 2018;10:e1–7.
Abassi M, Boulware DR, Rhein J. Cryptococcal meningitis: diagnosis and management update. Curr Trop Med Rep 2015;2:90–9.
Gaskell KM, Rothe C, Gnanadurai R, et al. A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi. PLoS One 2014;9:e110285.
Adeyemi BO, Ross A. Profile and acute mortality outcome of patients admitted with cryptococcal meningitis to an urban district hospital in KwaZulu-Natal, South Africa. Off J South Afr Acad Fam Pract Prim Care 2015;57:1–5.
Xu L, Zhang X, Guo Y, et al. Unique clinical features of cryptococcal meningitis among Chinese patients without predisposing diseases against patients with predisposing diseases. Medical Mycology 2019;57:944–53.
Liu ZY, Wang GQ, Zhu LP, et al. Expert consensus on the diagnosis and treatment of cryptococcal meningitis. Zhonghua Nei Ke Za Zhi 2018;57:317–23.
Liu L, Zhang R, Tang Y, et al. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus. Bioscience Trends 2014;8:327–32.
Stevens DA, Denning DW, Shatsky S, et al. Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications. Mycopathologia 1999;146:1–8.
Moritz D, Mena Lora AJ, Blumer B, et al. Recovery of Cryptococcus gattii from an infected ventriculo-peritoneal shunt, Illinois, USA. Emerg Infect Dis 2018;24:1382–3.
Liu J, Chen ZL, Li M, et al. Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis. BMC Neurol 2018;18:58.
Merkler AE, Ch’ang J, Parker WE, et al. The rate of complications after ventriculoperitoneal shunt surgery. World Neurosurg 2017;98:654–8.
Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010;50:291–322.
Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 2017;17:873–81.
Firacative C, Lizarazo J, Illnait-Zaragozí MT, et al. The status of cryptococcosis in Latin America. Mem Inst Oswaldo Cruz 2018;113:e170554.
Gassiep I, Aye C, Armstrong M, et al. Correlation between serum cryptococcal antigen titre and meningitis in immunocompetent patients. J Med Microbiol 2018;67:1515–8.
Tan ZR, Long XY, Li LG, et al. Spectrum of neuroimaging findings in cryptococcal meningitis in immunocompetent patients in China - a series of 18 cases. J Neurol Sci 2016;368:132–7.
Shapiro BB, Hedrick R, Vanle BC, et al. Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency. BMJ Case Rep 2018;2018:bcr-2017-221435.
Niknam N, Niknam N, Dushaj K, et al. A case of recurrent cryptococcal meningoencephalitis in an immunocompetent female. Case Rep Infect Dis 2014;2014:407348.
Li J, Wang P, Ye L, et al. Cryptococcal meningitis initially presenting with eye symptoms in an immunocompetent patient: a case report. Exp Ther Med 2016;12:1119–24.
Ito M, Hinata T, Tamura K, et al. Disseminated cryptococcosis with adrenal insufficiency and meningitis in an immunocompetent individual. Intern Med 2017;56:1259–64.
Liliang PC, Liang CL, Chang WN, et al. Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients. Clin Infect Dis 2003;37:673–8.
Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 infectious diseases society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis 2017;64:e34–65.
Escandon P, Lizarazo J, Agudelo CI, et al. Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia. Med Mycol 2013;51:765–8.
Chindamporn A, Chakrabarti A, Li R, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia Fungal Working Group (AFWG) initiative. Med Mycol 2018;56:416–25.
Abstracts from hydrocephalus 2018: the tenth meeting of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders. Fluids Barriers CNS 2018;15: (Suppl 2): 35.
Akhtar N, Khan AA, Yousaf M. Experience and outcome of ventricular-atrial shunt: a multi centre study. J Ayub Med Coll Abbottabad 2015;27:817–20.
Entry Date(s) :
Date Created: 20201021 Date Completed: 20201104 Latest Revision: 20210112
Update Code :
PubMed Central ID :
There are still no unified guidelines of surgical treatment and timing for human immunodeficiency virus (HIV)-negative patients with cryptococcal meningitis (CM).The clinical data and follow-up data were collected from HIV-negative CM patients in Xiangya Hospital of Central South University from January 2009 to November 2018, and 42 patients who were treated with surgical intervention were enrolled in the present study. These 42 patients were divided into ventriculoatrial (VA) group, ventriculoperitoneal group, external ventricle drainage (EVD) group, hydrocephalus (HYC) group, non-HYC group, EVD group, and non-EVD group (VA/ ventriculoperitoneal) according to different surgical procedures. Statistical analyses were conducted using SPSS (version 19.0, Chicago, IL).Signs of headache, fever, and loss of consciousness in the VA group were significantly improved compared with the EVD group at 1 week after operation (P < .05). The mortality rate of the VA group was significantly lower than that of the EVD group (P < .05). Moreover, male patients were more prone to have HYC (P < .05). Younger patients tended to develop HYC (P < .05). Cerebrospinal fluid sugar in the non-HYC group was significantly lower compared with the HYC group (P < .05). Time of CM-to-operation in the non-HYC group was markedly shorter compared with the HYC group (P < .01).VA procedure could be one of the first choices for the treatment of uncontrollable intracranial hypertension caused by CM. Severe uncontrollable headache, loss of consciousness, and cerebral hernia were indications of emergency surgery. Repeated headache, hearing impairment, and especially progressive loss of vision were indications of early surgery to avoid permanent damage to nerve functions of HIV-negative CM patients.